RESEARCH ARTICLE
Comorbidity of Depression and Anxiety: Association with Poor Quality of Life in Type 1 and 2 Diabetic Patients
Ana Claudia C. de Ornelas Maia1, *, Arthur de Azevedo Braga1, Flávia Paes1, Sergio Machado1, 2, 3, 4, Mauro Giovanni Carta5, Antonio Egidio Nardi1, Adriana Cardoso Silva1
Article Information
Identifiers and Pagination:
Year: 2013Volume: 9
First Page: 136
Last Page: 141
Publisher ID: CPEMH-9-136
DOI: 10.2174/1745017901309010136
Article History:
Received Date: 24/2/2013Revision Received Date: 18/5/2013
Acceptance Date: 19/5/2013
Electronic publication date: 12/7/2013
Collection year: 2013
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
Background:
Diabetes is associates with depression and impairment in Quality of Life (QoL).
Objective:
The objective is to define the frequencies of depressive and anxiety symptoms in a sample of patients diagnosed with type 1 and 2 diabetes, the amount of impairment of QoL and the weight of depression and anxiety in determining the QoL in such of patients.
Methods:
A total of 210 patients were divided into two groups (type 1 and type 2). Patients completed the HADS and WHOQoL-bref.
Results:
Groups showed a high prevalence of anxiety (type 1 = 60%, type 2 = 43.8%) and depression (type 1 = 52.4%, type 2 = 38.1%), both measures were significantly higher (p < 0.05) in diabetes type 1 patients. Type 1 patients also showed a QoL in the overall assessment and the physical, psychological and social relations domains. In both Type 1 and 2 diabetes poor QoL was found associated by anxiety and depression comorbidity.
Conclusion:
In overall diabetes patients depression and anxiety seems to be a determinant of poor QoL.
